217 related articles for article (PubMed ID: 23297298)
1. Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
Li L; Agarwal S; Elmquist WF
Drug Metab Dispos; 2013 Mar; 41(3):659-67. PubMed ID: 23297298
[TBL] [Abstract][Full Text] [Related]
2. pH-Dependent transport of pemetrexed by breast cancer resistance protein.
Li L; Sham YY; Bikadi Z; Elmquist WF
Drug Metab Dispos; 2011 Sep; 39(9):1478-85. PubMed ID: 21628496
[TBL] [Abstract][Full Text] [Related]
3. Organic anion transporter 3 mediates the efflux transport of an amphipathic organic anion, dehydroepiandrosterone sulfate, across the blood-brain barrier in mice.
Miyajima M; Kusuhara H; Fujishima M; Adachi Y; Sugiyama Y
Drug Metab Dispos; 2011 May; 39(5):814-9. PubMed ID: 21325432
[TBL] [Abstract][Full Text] [Related]
4. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
Assaraf YG
Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-Induced Attenuation of Prostaglandin D
Akanuma SI; Hashimoto K; Yoshida Y; Kubo Y; Hosoya KI
Biol Pharm Bull; 2020; 43(11):1669-1677. PubMed ID: 33132311
[TBL] [Abstract][Full Text] [Related]
6. Distribution of the novel antifolate pemetrexed to the brain.
Dai H; Chen Y; Elmquist WF
J Pharmacol Exp Ther; 2005 Oct; 315(1):222-9. PubMed ID: 15987831
[TBL] [Abstract][Full Text] [Related]
7. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
[TBL] [Abstract][Full Text] [Related]
8. The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
Sane R; Wu SP; Zhang R; Gallo JM
Drug Metab Dispos; 2014 Apr; 42(4):537-40. PubMed ID: 24464805
[TBL] [Abstract][Full Text] [Related]
9. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
10. Selective preservation of pemetrexed pharmacological activity in HeLa cells lacking the reduced folate carrier: association with the presence of a secondary transport pathway.
Zhao R; Hanscom M; Chattopadhyay S; Goldman ID
Cancer Res; 2004 May; 64(9):3313-9. PubMed ID: 15126375
[TBL] [Abstract][Full Text] [Related]
11. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs.
Mori S; Ohtsuki S; Takanaga H; Kikkawa T; Kang YS; Terasaki T
J Neurochem; 2004 Aug; 90(4):931-41. PubMed ID: 15287899
[TBL] [Abstract][Full Text] [Related]
12. Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).
Ose A; Ito M; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Hosokawa M; Schuetz JD; Sugiyama Y
Drug Metab Dispos; 2009 Feb; 37(2):315-21. PubMed ID: 19029202
[TBL] [Abstract][Full Text] [Related]
13. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
Römermann K; Fedrowitz M; Hampel P; Kaczmarek E; Töllner K; Erker T; Sweet DH; Löscher W
Neuropharmacology; 2017 May; 117():182-194. PubMed ID: 28192112
[TBL] [Abstract][Full Text] [Related]
14. Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats.
Shibayama Y; Ushinohama K; Ikeda R; Yoshikawa Y; Motoya T; Takeda Y; Yamada K
Cancer Sci; 2006 Nov; 97(11):1260-6. PubMed ID: 16925582
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
[TBL] [Abstract][Full Text] [Related]
17. Saturable active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier leads to nonlinear distribution of elacridar to the central nervous system.
Sane R; Agarwal S; Mittapalli RK; Elmquist WF
J Pharmacol Exp Ther; 2013 Apr; 345(1):111-24. PubMed ID: 23397054
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of pemetrexed transport by renal basolateral organic anion transporter hOAT3.
Kurata T; Iwamoto T; Kawahara Y; Okuda M
Drug Metab Pharmacokinet; 2014; 29(2):148-53. PubMed ID: 24042472
[TBL] [Abstract][Full Text] [Related]
19. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]